KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Receivables - Other (2019 - 2025)

Historic Receivables - Other for Xenon Pharmaceuticals (XENE) over the last 3 years, with Q3 2025 value amounting to $812000.0.

  • Xenon Pharmaceuticals' Receivables - Other changed N/A to $812000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $812000.0, marking a year-over-year change of. This contributed to the annual value of $1.5 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Receivables - Other of $812000.0 as of Q3 2025.
  • Xenon Pharmaceuticals' Receivables - Other's 5-year high stood at $1.5 million during Q4 2024, with a 5-year trough of $812000.0 in Q3 2025.